EG110A is a non-replicating HSV-1 vector designed to selectively silence the signals of type C sensory neurons responsible ...

After years of worrying that running or sneezing would leave me needing fresh underwear, a quick, minimally invasive procedure changed my life ...

About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...

A woman's decades-long struggle with incontinence was finally solved when doctors discovered a rare condition.

I am a 74-year-old man. I underwent bladder cystoscopy seven years ago, and since then I have been suffering from erectile dysfunction (with very weak erections). My testosterone levels are normal, ...

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

Report OverviewThe global botulinum toxin market is entering a phase of sustained expansion, with growth propelled by rising demand in both aesthetic and therapeutic domains. As a neurotoxin derived ...

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different perspective has ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

As temperature drops in the peak winter season resulting people generally reduce water intake and remain indoors with heaters, a ...

Comparing Coloplast to ConvaTec, the latter has been seeing double-digit growth in China, where Coloplast has been struggling ...